Take references from very standard respiration text books and tell me Classification of Pleural effusion, approach of extrapulmonary TB Especially Pleural TB

Reading File

Finding Sources

Searching PubMed

"pleural tuberculosis" AND diagnosis

Searching the Web

pleural tuberculosis extrapulmonary TB WHO treatment guideline diagnosis pleural effusion

Reading File

Finding Sources

Reading File

Reading Web Page

https://www.who.int/publications/i/item/9789240089787

Reading File

Finding Sources

Searching the Web

site:cdc.gov tuberculosis disease treatment extrapulmonary 6 months pleural tuberculosis regimen

1. Classification of pleural effusion

A. By pathophysiology: transudate vs exudate

This is the most useful initial classification because it directs the differential diagnosis and work-up.

Type	Basic mechanism	Common causes
Transudative effusion	Systemic imbalance in hydrostatic or oncotic pressure, with an otherwise normal pleura	Heart failure, cirrhosis with hepatic hydrothorax, nephrotic syndrome, hypoalbuminemia, peritoneal dialysis, myxedema
Exudative effusion	Local pleural disease causing increased capillary permeability, impaired lymphatic drainage, or fluid entry into pleura	Infection including TB, malignancy, pulmonary embolism, connective-tissue disease, pancreatitis, hemothorax, chylothorax, drug-related disease

Light's criteria

Pleural fluid is an exudate if any one of the following is present:

Pleural fluid protein / serum protein ratio > 0.5
Pleural fluid LDH / serum LDH ratio > 0.6
Pleural fluid LDH > two-thirds of the upper limit of normal serum LDH

If none is present, it is a transudate. Light's criteria are highly sensitive, but diuretic-treated heart failure may be misclassified as an exudate ("pseudoexudate"). In that setting, use the serum-pleural fluid albumin gradient.
Fishman's Pulmonary Diseases and Disorders, 2-volume set, p. 1352.
Symptom to Diagnosis: An Evidence-Based Guide, 4th ed., p. 4957-4973.

B. By cause or nature of fluid

Category	Examples
Hydrothorax	Serous, non-inflammatory fluid, commonly due to heart failure or cirrhosis
Parapneumonic effusion	Associated with pneumonia
Complicated parapneumonic effusion / empyema	Bacterial infection in pleural space; pus, positive Gram stain/culture, or adverse biochemistry may require drainage
Tuberculous pleural effusion	Usually a lymphocyte-predominant exudate
Malignant pleural effusion	Metastatic carcinoma, lymphoma, mesothelioma
Hemothorax	Pleural fluid hematocrit ≥50% of peripheral blood hematocrit
Chylothorax	Thoracic duct disruption or obstruction; triglyceride-rich chylous fluid
Pseudochylothorax	Chronic cholesterol-rich effusion, for example long-standing TB or rheumatoid pleuritis
Pancreatic effusion	High pleural-fluid amylase
Urinothorax	Usually transudative, with pleural-fluid creatinine higher than serum creatinine

C. By cell predominance in exudates

Neutrophil predominant: acute parapneumonic effusion, pulmonary embolism, early TB, pancreatitis.
Lymphocyte predominant: TB, malignancy, lymphoma, chronic rheumatoid pleuritis, chylothorax.
Eosinophil predominant: air or blood in pleural cavity, drugs, parasites, malignancy, pulmonary embolism. It is not diagnostic of a benign condition.
Predominantly malignant cells on cytology: malignant pleural effusion.

D. By imaging and complexity

Free-flowing vs loculated
Unilateral vs bilateral
Small, moderate, or massive
Simple vs complicated/septated
Pleural thickening or nodularity suggests a pleural process, especially malignancy or TB.

2. General approach to extrapulmonary tuberculosis (EPTB)

EPTB is TB involving organs outside the lung. Major sites include lymph nodes, pleura, genitourinary tract, bones and joints, meninges, peritoneum, and pericardium. A patient may have both pulmonary and extrapulmonary disease.
Harrison's Principles of Internal Medicine, 22nd ed., p. 1430.

Stepwise approach

Step 1: Recognize the clinical syndrome and risk factors

Consider EPTB in a patient with:

Subacute or chronic fever, night sweats, weight loss, anorexia
Known TB contact, prior TB, residence in a high-burden setting
HIV infection, diabetes, chronic kidney disease, malnutrition, immunosuppression, anti-TNF therapy, transplant status
Organ-specific manifestations:
- Cervical lymphadenopathy
- Pleural effusion
- Back pain or vertebral collapse
- Monoarthritis
- Meningitis
- Ascites/peritoneal thickening
- Pericardial effusion
- Sterile pyuria, urinary symptoms, infertility

Step 2: Look for concomitant pulmonary TB and assess infectivity

Even where disease appears extrapulmonary:

Chest radiograph, and CT chest when indicated
Sputum testing for AFB smear, mycobacterial culture, and molecular assay if cough, abnormal chest imaging, or sputum can be induced
Assess respiratory isolation needs if pulmonary/laryngeal TB is possible.

Step 3: Obtain the best specimen from the involved site

The core diagnostic principle is:

Obtain tissue or fluid from the affected site for microbiology and histopathology whenever safely possible.

Send relevant specimens for:

AFB smear
Mycobacterial culture, including drug-susceptibility testing
Rapid molecular test, such as Xpert MTB/RIF or equivalent, including rifampicin-resistance detection
Histopathology, looking for granulomas and caseation
Tests for alternate diagnoses, such as bacterial/fungal culture, cytology, lymphoma work-up, or autoimmune studies where appropriate.

EPTB is often paucibacillary, so a negative smear or molecular test from fluid does not exclude TB. Tissue sampling often has substantially higher diagnostic yield than fluid alone.

Step 4: Test for associated conditions before treatment

HIV test in all patients with suspected or confirmed TB
Baseline liver and renal function, complete blood count
Pregnancy status where relevant
Visual acuity/color vision before ethambutol, where feasible
Drug interaction review, especially antiretroviral therapy, anticoagulants, anticonvulsants, and transplant drugs
Assess for diabetes and immunosuppression.

Step 5: Treat confirmed, or strongly probable, drug-susceptible EPTB

For most forms of drug-susceptible EPTB, including pleural TB, treatment is usually the standard first-line regimen:

Intensive phase: 2 months of H + R + Z + E
Continuation phase: 4 months of H + R

This is written as 2HRZE/4HR, total 6 months, subject to national TB-program guidance, drug susceptibility, HIV status, and response. CDC guidance notes that the same basic principles apply to extrapulmonary disease, with 6-month therapy generally used except at selected sites such as the CNS, where longer treatment is customary. See the CDC extrapulmonary TB guidance.

Longer treatment is commonly considered for:

TB meningitis: generally 9-12 months
Bone and joint TB, especially spinal TB: often 9-12 months, depending on guideline, surgical issues, and clinical response
Selected complicated disease, drug resistance, or slow response.

Step 6: Identify EPTB forms requiring urgent specialist input

TB meningitis: urgent treatment, neuroimaging/CSF work-up as appropriate, corticosteroids.
Pericardial TB: assess for tamponade and constrictive physiology.
Spinal TB: assess for neurologic deficit, instability, deformity, or abscess.
Airway compromise from lymph nodes, large pleural effusion causing respiratory distress, or disseminated TB.
Suspected multidrug-resistant TB.

3. Pleural tuberculosis / tuberculous pleural effusion

Pleural TB is classified as extrapulmonary TB for reporting purposes, despite the pleura being intrathoracic.
Murray & Nadel's Textbook of Respiratory Medicine, 2-volume set, p. 1196.

Pathogenesis

The usual tuberculous pleural effusion is a delayed hypersensitivity response after a small number of bacilli reach the pleural space, often from a subpleural focus. Thus, it is usually paucibacillary.

Two forms should be distinguished:

Tuberculous pleuritis with effusion
- Common form
- Usually paucibacillary
- Pleural-fluid smear is commonly negative
Tuberculous empyema
- Less common
- Usually due to rupture of a cavity or adjacent pulmonary focus into pleura, often through a bronchopleural fistula
- Thick/cloudy fluid and a higher bacillary burden
- AFB smear and culture are more often positive
  Murray & Nadel's Textbook of Respiratory Medicine, 2-volume set, p. 1196.

Clinical features

Typical presentation is acute or subacute:

Fever
Pleuritic chest pain
Dry cough
Dyspnea, especially with a large effusion
Weight loss or night sweats may occur
Unilateral effusion is usual; bilateral effusions are uncommon.

Chest radiography demonstrates the effusion and may show associated parenchymal disease. Thoracic ultrasound confirms fluid, identifies loculations, and guides safe aspiration.

Pleural-fluid profile suggestive of TB

Typical fluid findings are:

Straw-colored, occasionally blood-stained
Exudative
Protein often >50% of serum protein
Usually lymphocyte predominant, especially later in disease
Early disease may be neutrophil predominant
Glucose normal to low
pH usually around 7.3, occasionally lower
Lymphocyte:neutrophil ratio commonly >0.75 in established disease.
Murray & Nadel's Textbook of Respiratory Medicine, 2-volume set, p. 1196.

A lymphocyte-rich exudate should particularly raise the differential of TB, malignancy, lymphoma, chronic rheumatoid pleuritis, and chylothorax. It is not by itself diagnostic of TB.

Diagnostic approach to suspected pleural TB

1. Initial assessment

Clinical TB risk and symptoms
Chest radiograph and thoracic ultrasound
CT chest if parenchymal lesions, lymphadenopathy, pleural thickening, malignancy, or loculations need assessment
Sputum AFB smear, culture, and molecular testing, including induced sputum if necessary
HIV testing.

2. Diagnostic thoracentesis

Send pleural fluid for:

Appearance
Total and differential leukocyte count
Protein, LDH, glucose, pH with paired serum protein and LDH
Gram stain and bacterial culture
Cytology
AFB smear and mycobacterial culture
Molecular assay such as Xpert MTB/RIF, if available
ADA in a suitable clinical setting
Consider interferon-gamma where available.

3. Interpreting ADA

High pleural-fluid ADA supports pleural TB in a compatible lymphocytic exudate and in a high-prevalence setting. The threshold depends on laboratory method and local population. Commonly used cutoffs are around 35-40 U/L.

However:

ADA is not a stand-alone confirmation test.
False positive ADA can occur with parapneumonic effusion/empyema, lymphoma, and some inflammatory pleural diseases.
ADA can be less reliable in advanced age and immunosuppression, including HIV.

Murray & Nadel reports good diagnostic performance at ADA >35 U/L in appropriate patients, but warns about false positives and reduced utility in immunosuppression.
Murray & Nadel's Textbook of Respiratory Medicine, 2-volume set, p. 1197.

4. Pleural biopsy when fluid testing is non-diagnostic

A diagnosis is confirmed by either:

Demonstrating M. tuberculosis in pleural fluid or tissue by microscopy, culture, or molecular test, or
Demonstrating caseating granulomas in pleural tissue.

Because the disease is paucibacillary, pleural-fluid AFB smear is rarely positive and pleural-fluid culture has limited sensitivity. Pleural tissue provides greater yield.

Options:

Image-guided pleural biopsy
Closed needle biopsy, with multiple tissue samples for histology, AFB stain, culture, and molecular testing
Medical thoracoscopy/pleuroscopy, especially if diagnosis remains unclear or malignancy is a concern.

Murray & Nadel notes that fluid culture is positive in only about 20-40% of proven non-empyematous pleural TB cases; multiple pleural biopsy samples and thoracoscopy materially improve yield.
Murray & Nadel's Textbook of Respiratory Medicine, 2-volume set, p. 1197.

Treatment of pleural TB

Drug treatment

For drug-susceptible pleural TB:

2 months HRZE, followed by
4 months HR

Use weight-based doses and directly observed or supported treatment according to local program policy. Obtain culture and drug-susceptibility results whenever possible, because these determine whether the regimen should be modified.

Drainage

Diagnostic aspiration is required for most new unilateral exudative effusions.
Therapeutic aspiration is appropriate for a large effusion causing significant dyspnea or hypoxemia.
Routine repeated drainage solely to prevent residual pleural thickening is not generally required.
Chest-tube drainage is indicated for tuberculous empyema, frank pus, bronchopleural fistula, or a complex infected/loculated collection.
Persistent pleural thickening, trapped lung, or chronic TB empyema may require thoracic-surgery input.

Corticosteroids

Routine corticosteroids are not recommended for uncomplicated tuberculous pleural effusion. They may hasten symptomatic or radiographic resolution in some situations but do not reliably prevent residual pleural thickening and can cause adverse effects. Steroids have clearer roles in selected other EPTB forms, especially TB meningitis and sometimes TB pericarditis.

Practical examination-style algorithm

Unilateral pleural effusion with TB suspected
→ Chest X-ray + ultrasound
→ Sputum for AFB/culture/molecular testing
→ Diagnostic pleural tap
→ Confirm exudate by Light's criteria
→ Pleural-fluid differential, ADA, AFB smear/culture, molecular test, cytology
→ If lymphocytic exudate with high ADA and compatible epidemiology, TB becomes likely
→ Seek microbiologic or histologic confirmation whenever feasible
→ If non-diagnostic, image-guided pleural biopsy or thoracoscopy
→ Start appropriate anti-TB treatment once confirmed, or when the cumulative evidence is sufficiently strong and dangerous alternatives have been reasonably excluded.

Classification of Pleural effusion based on amount

Reading File

Finding Sources

Searching PubMed

"pleural effusion" AND classification

Searching the Web

pleural effusion size classification small moderate massive one third two thirds hemithorax guideline

Classification of pleural effusion by amount on chest radiograph

A commonly used practical classification is based on the proportion of the affected hemithorax occupied by fluid:

Size	Amount of hemithorax occupied
Small effusion	< one-third of the hemithorax
Moderate effusion	One-third to two-thirds of the hemithorax
Large effusion	> two-thirds of the hemithorax
Massive effusion	Near-complete or complete opacification of one hemithorax, often with contralateral mediastinal shift

Exam answer:

Pleural effusion is classified radiologically as small when it occupies less than one-third of a hemithorax, moderate when it occupies one-third to two-thirds, and large when it occupies more than two-thirds. A massive effusion causes near-total or total opacification of the hemithorax and may shift the mediastinum to the opposite side.

There is some variation in radiology terminology, and no single universally accepted CT volume cutoff. But the one-third / two-thirds hemithorax system is widely used clinically and in examinations. A massive effusion generally refers to one occupying nearly the whole hemithorax.

Murray & Nadel's Textbook of Respiratory Medicine, 2-volume set, p. 1196, notes that tuberculous effusions are usually small to moderate but can occupy the entire hemithorax.

Can u quantify

Reading File

Finding Sources

Searching PubMed

"pleural effusion" AND volume

Searching the Web

pleural effusion small moderate large volume mL ultrasound chest radiograph quantification

There is no universally accepted exact mL-based classification for pleural effusion. In practice, classify it by imaging appearance, with approximate volumes as follows:

Amount	Approximate volume	Usual radiographic description
Minimal / very small	<100 mL	Often not evident on PA chest X-ray; may be seen on ultrasound or lateral decubitus film
Small	100-500 mL	Blunting of the costophrenic angle
Moderate	500-1,500 mL	Fluid occupies a substantial lower part of hemithorax
Large	>1,500 mL	More than about two-thirds of hemithorax
Massive	Usually >2,000 mL, variable	Near-complete/complete opacification of one hemithorax, often with mediastinal shift to the opposite side

Useful X-ray correlations

~75 mL: posterior costophrenic angle may become obscured on lateral chest X-ray.
~150-200 mL: blunting of the lateral costophrenic angle or meniscus may appear on erect PA chest X-ray.
~500 mL: hemidiaphragm may become obscured; dyspnea becomes more likely.
>1.5-2 L: often produces a large or massive radiographic effusion.

Goldman-Cecil Medicine, 2-volume set, p. 1287: approximately 75 mL obscures the posterior costophrenic sulcus and 150 mL obscures the lateral costophrenic sulcus.
Frameworks for Internal Medicine, pleural disease section: PA meniscus is generally evident with >200 mL, and hemidiaphragm obscuration occurs around 500 mL.

For an exam, write:

By volume, pleural effusion may be minimal (<100 mL), small (100-500 mL), moderate (500-1500 mL), large (>1500 mL), or massive (usually >2 L, causing near-total hemithorax opacification).

This is a shared conversation. Sign in to Orris to start your own chat.